ADMET & DMPK

ADMET & DMPK

Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs

Yazarlar: Klara Valko, Silvia Rava, Shenaz Bunally, Scott Anderson

Cilt 8 , Sayı 1 , 2020 , Sayfalar 78-97

Konular:-

DOI:10.5599/admet.757

Anahtar Kelimeler:Phospholipid binding,HPLC,Volume of distribution,Tissue binding,Drug efficiency

Özet: Immobilized Artificial Membrane (IAM) chromatography columns have been used to model the in vivo distribution of drug discovery compounds. Regis Technologies Inc., the manufacturer, had to replace the silica support and consequently introduced a new IAM.PC.DD2 column that shows slightly different selectivity towards acidic and basic compounds. The application of the new IAM.PC.DD2 columns has been evaluated and the in vivo distribution models have been compared with the previous batches of columns. It was found that due to the improved endcapping of the silica, some of the positively charged drug molecules showed shorter retention than previously published. Therefore, the column system suitability data have been updated. However, these differences do not significantly affect the previously published models for the volume of distribution, brain tissue binding and drug efficiency. Therefore, the published models can be used with the new IAM.PC.DD2 columns.

ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır
KAYNAK GÖSTER
BibTex
KOPYALA
@article{2020, title={Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs}, volume={8}, number={78–97}, publisher={ADMET & DMPK}, author={Klara Valko, Silvia Rava, Shenaz Bunally, Scott Anderson}, year={2020} }
APA
KOPYALA
Klara Valko, Silvia Rava, Shenaz Bunally, Scott Anderson. (2020). Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs (Vol. 8). Vol. 8. ADMET & DMPK.
MLA
KOPYALA
Klara Valko, Silvia Rava, Shenaz Bunally, Scott Anderson. Revisiting the Application of Immobilized Artificial Membrane (IAM) Chromatography to Estimate in Vivo Distribution Properties of Drug Discovery Compounds Based on the Model of Marketed Drugs. no. 78–97, ADMET & DMPK, 2020.
Atıf Görüntüle
PDF Görüntüle
Kaynak Görüntüle
Paylaş
Dergi Bilgileri